David Lawrence - Net Worth and Insider Trading
David Lawrence Net Worth
The estimated net worth of David Lawrence is at least $31 dollars as of 2024-06-07. David Lawrence is the Chief, Bus. Ops & PAO of Acorda Therapeutics Inc and owns about 108 shares of Acorda Therapeutics Inc (ACORQ) stock worth over $31. Details can be seen in David Lawrence's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Lawrence has not made any transactions after 2019-12-02 and currently still holds the listed stock(s).
Transaction Summary of David Lawrence
David Lawrence Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Lawrence owns 1 companies in total, including Acorda Therapeutics Inc (ACORQ) .
Click here to see the complete history of David Lawrence’s form 4 insider trades.
Insider Ownership Summary of David Lawrence
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACORQ | Acorda Therapeutics Inc | 2019-12-02 | Chief Financial Officer |
David Lawrence Latest Holdings Summary
David Lawrence currently owns a total of 1 stock. David Lawrence owns 108 shares of Acorda Therapeutics Inc (ACORQ) as of December 2, 2019, with a value of $31.
Latest Holdings of David Lawrence
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACORQ | Acorda Therapeutics Inc | 2019-12-02 | 108 | 0.29 | 31 |
Holding Weightings of David Lawrence
David Lawrence Form 4 Trading Tracker
According to the SEC Form 4 filings, David Lawrence has made a total of 1 transactions in Acorda Therapeutics Inc (ACORQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acorda Therapeutics Inc is the sale of 10 shares on December 2, 2019, which brought David Lawrence around $1,882.
Insider Trading History of David Lawrence
- 1
David Lawrence Trading Performance
David Lawrence Ownership Network
David Lawrence Owned Company Details
What does Acorda Therapeutics Inc do?
Who are the key executives at Acorda Therapeutics Inc?
David Lawrence is the Chief Financial Officer of Acorda Therapeutics Inc. Other key executives at Acorda Therapeutics Inc include CEO and President Ron Cohen , Chief Financial Officer Michael A Gesser , and General Counsel Neil S. Belloff .
Acorda Therapeutics Inc (ACORQ) Insider Trades Summary
Over the past 18 months, David Lawrence made no insider transaction in Acorda Therapeutics Inc (ACORQ). Other recent insider transactions involving Acorda Therapeutics Inc (ACORQ) include a net purchase of 20,156 shares made by Ron Cohen ,
In summary, during the past 3 months, insiders sold 0 shares of Acorda Therapeutics Inc (ACORQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acorda Therapeutics Inc (ACORQ) were sold and 1,008 shares were bought by its insiders, resulting in a net purchase of 1,008 shares.
Acorda Therapeutics Inc (ACORQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acorda Therapeutics Inc Insider Transactions
David Lawrence Mailing Address
Above is the net worth, insider trading, and ownership report for David Lawrence. You might contact David Lawrence via mailing address: C/o Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley Ny 10502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
